Naloxone hydrochloride and Lidocaine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naloxone hydrochloride (naloxone hydrochloride) and Lidocaine (lidocaine). Common drug interactions include blood bicarbonate decreased among females and acute generalised exanthematous pustulosis among males.

The phase IV clinical study analyzes what interactions people have when they take Naloxone hydrochloride and Lidocaine. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Naloxone hydrochloride?

Naloxone hydrochloride has active ingredients of naloxone hydrochloride. eHealthMe is studying from 512 Naloxone hydrochloride users. Check the latest studies of Naloxone hydrochloride.

What is Lidocaine?

Lidocaine has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 27,555 Lidocaine users. Check the latest studies of Lidocaine.



On Jul, 19, 2026

22 people who take Naloxone hydrochloride and Lidocaine together, and have interactions are studied.

Naloxone hydrochloride and Lidocaine drug interactions.

What are the common drug interactions of Naloxone Hydrochloride and Lidocaine, by gender? *:

female:

  1. Blood bicarbonate decreased
  2. Blood ph decreased
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Depressed level of consciousness
  5. Haemoglobin decreased
  6. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  7. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  8. Hypotension (abnormally low blood pressure)
  9. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  10. Mydriasis (a dilation of the pupil)

male:

  1. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  4. Streptococcal infection
  5. Unresponsive to stimuli
  6. Blood culture positive
  7. Oropharyngeal pain
  8. White blood cell count decreased
  9. Drug ineffective
  10. Respiratory depression (respiration has a rate below 12 breaths)

What are the common drug interactions of Naloxone Hydrochloride and Lidocaine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cardiogenic shock (inadequate circulation of blood)
  2. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  3. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)

20-29:

  1. Blood carbon dioxide increased
  2. Blood ph decreased
  3. Dyspnoea (difficult or laboured respiration)
  4. Po2 decreased
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Sputum discoloured

30-39:

  1. Blood bicarbonate decreased
  2. Blood ph decreased
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Depressed level of consciousness
  5. Haemoglobin decreased
  6. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  7. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  8. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  9. Mydriasis (a dilation of the pupil)
  10. Nausea (feeling of having an urge to vomit)

40-49:

n/a

50-59:

  1. Drug abuse
  2. Pneumonia bacterial (pneumonia associated with bacterial infection)

60+:

  1. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  4. Streptococcal infection
  5. Unresponsive to stimuli
  6. Blood culture positive
  7. Oropharyngeal pain
  8. White blood cell count decreased
  9. Drug ineffective
  10. Respiratory depression (respiration has a rate below 12 breaths)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 3 people, 13.64%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.09%
  3. High Blood Pressure: 2 people, 9.09%
  4. General Anaesthesia: 2 people, 9.09%
  5. Depression: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Naloxone hydrochloride and Lidocaine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naloxone hydrochloride and Lidocaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naloxone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lidocaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naloxone hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidocaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naloxone hydrochloride and lidocaine (the active ingredients of Naloxone hydrochloride and Lidocaine, respectively), and Naloxone hydrochloride and Lidocaine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: